Core Insights - SeedlingLabs has appointed Dr. Sudhir Kumar Patnaik as the first member of its Advisory Board, marking a significant milestone in the company's growth as it scales its AI-native platform and production capabilities [1][2] Company Overview - SeedlingLabs is an AI-native Product Development as a Service (PDaaS) company designed for enterprise-grade execution, enabling startups and product-led enterprises to build, deploy, and scale AI-powered products with reliability [12][13] - The company aims to address the challenges organizations face in moving AI from prototype to production, focusing on operational reliability, security, and resilience [3][4] Leadership and Expertise - Dr. Sudhir Kumar Patnaik brings over 28 years of experience in global technology leadership, having held senior roles in major technology firms and academia, which will be invaluable for SeedlingLabs as it grows [4][6][8] - His role will focus on three strategic priorities: designing enterprise-grade AI-native platforms, building AI talent and capabilities, and fostering industry-academia collaboration [9][10] Strategic Initiatives - The 'Nursery to Naukri' initiative aims to develop industry-ready AI practitioners at scale, aligning with SeedlingLabs' vision to democratize high-end engineering opportunities [10][11] - The company emphasizes building durable systems and processes to ensure that AI solutions are reliable and effective in production environments [11]

Core Insights - Dassault Systèmes has reported on the liquidity contract with Oddo BHF SCA, detailing transactions and resources as of December 31, 2025 [1][8]. Group 1: Liquidity Contract Overview - The liquidity contract was implemented on January 7, 2015, and updated on June 18, 2019 [1]. - As of December 31, 2025, the liquidity account held 925,197 shares of Dassault Systèmes and €5,384,754.01 in cash [3]. - Initial resources at the time of the contract's implementation included 0 shares and €10,000,000 in cash [3]. Group 2: Transaction Details - From July 1, 2025, to December 31, 2025, a total of 20,126 purchases and 22,371 sales were executed [4]. - The total volume of securities traded during this period amounted to 4,863,746 shares purchased for €128,747,093 and 4,796,309 shares sold for €128,114,812.54 [4]. - Specific transaction examples include purchases of 40,000 shares on July 7, 2025, for €1,246,769.05 and sales of 69,000 shares on July 10, 2025, for €2,236,435.00 [4]. Group 3: Financial Contributions - Amendments to the liquidity agreement included an additional €5,000,000 contribution on October 26, 2017, raising the total to €15,000,000, and another €5,000,000 contribution on December 13, 2018, increasing it to €20,000,000 [3]. - At the time of the new liquidity contract implementation on June 18, 2019, the account had 62,557 shares and €17,496,140.38 in cash [3].

Core Viewpoint - Dassault Systèmes announced the total number of outstanding shares and voting rights as of December 31, 2025, highlighting its corporate governance and shareholder engagement practices [2]. Group 1: Outstanding Shares and Voting Rights - The total number of outstanding shares is reported as 1,341,806,268 [2]. - The total number of voting rights is calculated to be 2,013,578,477, which includes shares with suspended voting rights as per regulatory guidelines [2]. Group 2: Regulatory Compliance - The announcement complies with articles 223-16 and 221-3 of the General Regulation of the Autorité des marchés financiers, ensuring transparency in shareholder communications [2]. - Shareholders are encouraged to refer to Article 223-11 for details on declaring crossing of thresholds related to shareholdings and voting rights [2]. Group 3: Company Overview - Dassault Systèmes has been a pioneer in creating virtual worlds since 1981, aiming to enhance real-life experiences for consumers, patients, and citizens [3]. - The company serves 370,000 customers across various industries through its 3DEXPERIENCE platform, promoting sustainable innovations [3].

Core Points - Dassault Systèmes announced the total number of outstanding shares and voting rights as of December 31, 2025, with 1,341,806,268 outstanding shares and 2,013,578,477 voting rights [2]. Group 1 - The number of outstanding shares is reported as 1,341,806,268 [2]. - The total number of voting rights is calculated based on the outstanding shares, totaling 2,013,578,477 [2]. - The calculation of voting rights includes shares with suspended voting rights, as per regulatory guidelines [2]. Group 2 - Shareholders are advised to refer to Article 223-11 of the General Regulation for declaring crossing of thresholds [2]. - Declarations related to crossing of thresholds must be sent to Dassault Systèmes' Investor Relations Service [3]. - The company emphasizes its role as a catalyst for human progress through its 3DEXPERIENCE platform, serving 370,000 customers across various industries [3].

Core Insights - Flint has commenced production of its cellulose-based, biodegradable batteries in Singapore, transitioning from lab-scale development to manufacturing ready for pilot deployments and customer programs [1][2] Production and Technology - The company is producing rechargeable, non-toxic battery cells designed for safety, including non-flammability and non-explosiveness, with two products set to be unveiled at CES 2026 [2][7] - Flint's production line utilizes proprietary cellulose-based architecture and water-based manufacturing methods, reducing reliance on traditional battery materials like lithium and cobalt, while promoting lower-carbon manufacturing [3][4] Expansion and Recognition - Flint has expanded into a new facility over 8,000 square feet to pilot new processes, scale manufacturing, and continue R&D for next-generation battery architectures [4] - The company received the Best of CES Sustainability Award at CES 2025, enhancing its global visibility and commercial traction [5][6] Partnerships and Collaborations - Flint is engaged in pilot deployments with major technology companies, including Logitech and Amazon, and has been selected for innovation programs such as the Climate Tech Accelerator by MIT [8] - The company raised US$2 million in a pre-Series A funding round to support its asset-light growth model [6] Future Plans - Flint is preparing to scale its manufacturing capacity in Europe and is in discussions with a major contract manufacturer [9] - The company is also developing a solid-state derivative of its cellulose-based chemistry aimed at higher-density rechargeable applications [10] Market Engagement - With production underway, Flint is open to collaborations and orders, prioritizing pilot deployments and initial commercial rollouts [11]

Core Points - Dassault Systèmes announced the total number of outstanding shares and voting rights as of November 30, 2025, with 1,341,782,567 outstanding shares and 2,013,594,540 voting rights [2][4] Group 1 - The number of outstanding shares is reported as 1,341,782,567 [2] - The total number of voting rights is calculated based on the outstanding shares, including those with suspended voting rights [2] - Shareholders are advised to refer to Article 223-11 of the General Regulation for details on declaring crossing of thresholds [2][3]

Core Insights - Caidya has invested in Medidata's Clinical Trial Management System (CTMS) and Clinical Data Studio to enhance its service offerings and improve data-driven decision-making across various therapeutic areas [1][2] Company Overview - Caidya is a global, full-service contract research organization (CRO) specializing in complex, multi-regional trials across oncology, hematology, rare diseases, pediatrics, cell and gene therapy, cardiovascular, and dermatology [6][3] - The organization operates in over 50 countries and regions, emphasizing a superior customer experience through personalized solutions throughout the clinical development lifecycle [6][3] Partnership and Technology Integration - The partnership with Medidata positions Caidya to leverage AI-powered insights within CTMS, leading to improved execution and patient outcomes [2][3] - Clinical Data Studio will enable sponsors to optimize data aggregation and management workflows, potentially reducing review cycles by up to 80% [2] Industry Positioning - Caidya is recognized as a frontrunner in the mid-sized CRO segment, setting a new standard for modern CROs through its investment in advanced solutions [3] - The collaboration with Medidata reflects a broader industry shift towards digital transformation, characterized by speed, agility, and trust [3]

Core Insights - Medidata has launched the Medidata Data Experience, which includes Health Record Connect and Rave Companion, aimed at expediting the development of life-saving medicines for patients by integrating electronic health records (EHR) into clinical trials [1][2] Group 1: Medidata Data Experience - The Medidata Data Experience will be available to select National Cancer Institute (NCI) Lead Protocol Organizations (LPO), facilitating the automatic elevation of patient data from EHR systems into the Medidata Platform [1] - The integration of Health Record Connect and Rave Companion is expected to reduce administrative burdens, enhance insights, and allow clinical sites to focus more on patient care [1][2] Group 2: Benefits of the New Solutions - The new solutions aim to solve the industry's long-standing challenge of using EHR in clinical studies, enabling NCI LPOs to input data up to 90% faster [2] - By minimizing duplicative tasks for research sites, the technology is designed to accelerate timelines and improve overall data quality, enhancing the experience for both researchers and patients [2] Group 3: Medidata's Experience and Impact - Medidata has supported the NCI Cancer Therapy Evaluation Program (CTEP) for 17 years, reinforcing NCI's ability to manage clinical operations effectively [3] - The company has a strong track record, having powered over 36,000 trials and served 11 million patients, showcasing its expertise and extensive clinical trial data set [4]

Market Environment - Global equities experienced an upward trend during the quarter, with 10 out of 11 GICS sectors showing positive returns. Information technology and financials were the primary contributors, while consumer staples were the only detractor [2] - The U.S. was the main driver of positive market momentum, followed by Japan, while Denmark and Germany slightly detracted from overall performance [2] Portfolio Performance - The portfolio achieved a net return of 1.83% for the reporting period, compared to the MSCI World Index's return of 7.27% [3] Top Contributors - Alibaba Group (BABA) saw significant stock price appreciation due to strong earnings reflecting rapid growth in Chinese AI and healthy revenue growth in its Cloud segment, with expectations for continued momentum [4] - Alphabet (GOOG)(GOOGL) benefited from a favorable ruling in an antitrust case and exceeded second-quarter earnings expectations, with innovations in Google Search driving engagement and revenue [5] - IQVIA Holdings (IQV) experienced stock price appreciation after solid second-quarter results, indicating growth potential in its technology and analytics solutions segment [6] Top Detractors - Charter Communications (CHTR) faced a decline in stock price due to weak second-quarter earnings and a faster-than-expected drop in broadband subscriptions, although ARPU growth accelerated [7] - Centene (CNC) saw its stock price decline after withdrawing and then lowering its 2025 earnings per share guidance due to cost pressures in its Medicaid and Marketplace businesses [8] - CNH Industrial (CNH) reported weak results and reaffirmed guidance amidst challenging conditions, with management expecting a rebound in 2025 and significant margin expansion potential [9] Portfolio Positioning - The company initiated a position in Dassault Systèmes, a French software firm specializing in virtual twin technology, which is expected to drive innovation and cost reduction, despite a nearly 40% decline in share price from its peak [10] Outlook - The company notes a shift in market dynamics, with a decline in U.S. growth/momentum stocks and improved fundamentals in European equities, suggesting a potential for continued investor interest in this region [13]

Core Points - Dassault Systèmes announced the total number of outstanding shares and voting rights as of October 31, 2025, with 1,341,772,015 outstanding shares and 2,013,588,275 voting rights [2][4] Group 1 - The number of outstanding shares is reported as 1,341,772,015 [2] - The total number of voting rights is calculated based on the outstanding shares, including those with suspended voting rights [2] - Shareholders are advised to refer to Article 223-11 of the General Regulation for details on declaring crossing of thresholds [2][3]